Results 141 to 150 of about 102,321 (240)
Background and Purpose: Regarding usefulness of revascularization versus optimal medical therapy in patients with stable angina pectoris, data are challenging.
Maryam Nabati +4 more
doaj
Coronary sinus intervention for the treatment of refractory angina pectoris
Yoav Paz1,3, Amihay Shinfeld2,31General Intensive Care Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; 2Department of Cardiac Surgery, Chaim Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel; 3Sackler Faculty of Medicine, Tel Aviv University,
Paz Y, Shinfeld A
core
Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men [PDF]
Lowe, G.D. +6 more
core +1 more source
Az angina pectoris első klinikai feljegyzése William Heberden nevéhez köthető 1768-ból és ezt követően, majd egy évszázadra volt szükség, hogy az első vasodilatátor hatású készítményt felfedezzék és később hatékonyan alkalmazzák. Fizikai terhelésre és
Pap, Rita
core
Combined discriminative value of SII and sdLDL-C for 1-year major adverse cardiovascular events in patients with unstable angina pectoris. [PDF]
Zhao Q, Peng L, Li L.
europepmc +1 more source
Combined use of clopidogrel and atorvastatin for angina pectoris caused by coronary heart disease: clinical effectiveness, safety, and contributing factors. [PDF]
Wang Y, Chang F, Cui M, Xue J.
europepmc +1 more source
Angina Pectoris Following Latanoprostene Bunod 0.024% Administration: A Case Report. [PDF]
Edakkavil Z +4 more
europepmc +1 more source
Svår symtomgivande angina pectoris, trots optimal medikamentell och invasiv terapi, definieras internationellt som refraktär angina pectoris. Ett flertal additiva behandlingsmetoder har utvecklats och visat symtomlindrande effekt i studier av varierande ...
Börjesson, Mats, +3 more
core
Unexpected coronary vasospasm: a case of systemic minoxidil-induced angina pectoris. [PDF]
Pavrey R, Chauhan V.
europepmc +1 more source

